| Serena E Smith, MS, CCC-SLP | |
|
115 Little St, Manchester, KY 40962-1233 | |
| (606) 391-6224 | |
| Not Available |
| Full Name | Serena E Smith |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 115 Little St, Manchester, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851035703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 276065 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Serena E Smith, MS, CCC-SLP 115 Little St, Manchester, KY 40962-1233 Ph: (606) 391-6224 | Serena E Smith, MS, CCC-SLP 115 Little St, Manchester, KY 40962-1233 Ph: (606) 391-6224 |
News Archive
Business Insurance: "The once politically popular program that provides COBRA premium subsidies for involuntarily terminated employees is winding down as broad congressional support has nearly vanished, experts say. Embedded in a 2009 economic stimulus measure and renewed several times since then, the program in which the federal government pays 65% of the COBRA premium has enabled millions of employees who lost their jobs and their dependents to keep group coverage by making it more affordable."
A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal professor.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it has dosed the first subjects in a Phase 2, placebo-controlled, dose-finding study of its ARX-04 sufentanil NanoTab product candidate.
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University (LMU) of Munich to coordinate a European Union grant for Phase 2 clinical trials of SQ109 in adult pulmonary tuberculosis (TB) in seven sites in Africa.
Gov. Terry McAuliffe will fly to southwest Virginia to draw attention to the uninsured as he continues his campaign to expand Medicaid.
› Verified 1 days ago
Mrs. Whitney Dawn Griffin, B.S, M.A Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 376 Manchester Square Shpg Ctr, Manchester, KY 40962 Phone: 606-598-7673 Fax: 606-599-8549 | |
Mrs. Dinah Lynn Sowders, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 561 Mill Pond Drive, Manchester, KY 40962 Phone: 606-598-6077 Fax: 606-599-1402 | |
Mrs. Vanda Laura Rice, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8212 Highway 638, Manchester, KY 40962 Phone: 606-598-7274 Fax: 606-599-2389 | |
Lisa Parks, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Little St, Manchester, KY 40962 Phone: 606-391-6224 Fax: 606-402-2125 | |
Ms. Rhonda Renee Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1195 Highway 687, Manchester, KY 40962 Phone: 606-813-4333 | |
Mrs. Angela Mae Williams, MA,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 77 Mize Branch Rd, Manchester, KY 40962 Phone: 606-493-6957 | |
Whitney Kala Goodin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1033 N Highway 11, Manchester, KY 40962 Phone: 606-598-6163 |